mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
0.076 |
0.03 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.03 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |
mRNA |
TAE684 |
CCLE |
pan-cancer |
AAC |
0.095 |
0.03 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.12 |
0.03 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.03 |
mRNA |
PIK-93 |
GDSC1000 |
pan-cancer |
AAC |
-0.06 |
0.03 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.03 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.068 |
0.03 |
mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.04 |